Figure 2.

Serum levels of HBcAb at different timepoints according to whether HBeAg seroconversion occurred at week 96.

Notes: Stratification of patients according to whether or not HBeAg seroconversion occurred or not at week 96. The baseline mean quantitative serum HBcAb levels were 4.38 ± 0.54 and 4.02 ± 0.58 log₁₀ IU/mL in groups with and without HBeAg seroconversion, respectively (P = 0.029). The mean serum HBcAb level in the group with HBeAg seroconversion decreased to 3.69 ± 0.39 log₁₀ IU/mL at week 24 and to 3.42 ± 0.46 log₁₀ IU/mL at week 48, and decreased to 3.53 ± 0.57 and 3.27 ± 0.52 log₁₀ IU/mL at weeks 24 and 48 in the group without HBeAg seroconversion.